CATEGORY:
Clinical Trials
TITLE:
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
INTERVENTION/TREATMENT:
PHASE:
DESCRIPTION:
Conditions : Presbycusis; Hearing Loss, Sensorineural; Noise Induced Hearing Loss; Sudden Hearing Loss
Interventions : Drug: FX-322; Other: placebo
Sponsor : Frequency Therapeutics
Recruiting
ID:
NCT04601909
STATUS:
DATE – FIRST POSTED:
Mon, 26 Oct 2020 12:00:00 EDT
DATE – LAST UPDATE POSTED:
10/26/20 07:11AM
DATE – RETRIEVED:
10/26/20 07:11AM
LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT04601909
LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT04601909